Dr Brian Tse
Faculty of Health,
School of Biomedical Sciences
Personal details
Positions
- Visiting Fellow
Faculty of Health,
School of Biomedical Sciences
Research field
Medical Microbiology, Oncology and Carcinogenesis
Field of Research code, Australian and New Zealand Standard Research Classification (ANZSRC), 2008
Qualifications
- Doctor of Philosophy (University of New South Wales)
Publications
- Huang, X., Ali, T., Nano, T., Blick, T., Tse, B., Sokolowski, K., Tourell, M., Lloyd, T., Thompson, R., Momot, K. & Hugo, H. (2019). Quantification of breast tissue density: Correlation between single-sided portable NMR and micro-CT measurements. Magnetic Resonance Imaging, 62, 111–120. https://eprints.qut.edu.au/130727
- Tse, B., Volpert, M., Ratther, E., Stylianou, N., Nouri, M., McGowan, K., Lehman, M., McPherson, S., Roshan-Moniri, M., Butler, M., Caradec, J., Gregory-Evans, C., McGovern, J., Williams, E., Gunter, J., Russell, P., Nelson, C., Hollier, B. & other, a. (2017). Neuropilin-1 is upregulated in the adaptive response of prostate tumors to androgen-targeted therapies and is prognostic of metastatic progression and patient mortality. Oncogene, 36(24), 3417–3427. https://eprints.qut.edu.au/107515
- Thomas, P., Samaratunga, H., Vela, I., Gobe, G., Wood, S., Rhee, H., Lim Ng, K., Tse, B., Yeh, M., Russell, P. & Nelson, C. (2016). Using prostate specific membrane antigen (PSMA) expression in clear cell renal cell carcinoma for imaging advanced disease [Correspondence]. Pathology, 48(6), 613–616. https://eprints.qut.edu.au/103511
- Fuchs, A., Tse, B., Pearce, A., Yeh, M., Fletcher, N., Huang, S., Heston, W., Whittaker, A., Russell, P. & Thurecht, K. (2015). Evaluation of polymeric nanomedicines targeted to PSMA: Effect of ligand on targeting efficiency. Biomacromolecules, 16(10), 3235–3247. https://eprints.qut.edu.au/94652
- Tse, B., Cowin, G., Soekmadji, C., Jovanovic, L., Vasireddy, R., Ling, P., Khatri, A., Liu, T., Thierry, B. & Russell, P. (2015). PSMA-targeting iron oxide magnetic nanoparticles enhance MRI of preclinical prostate cancer. Nanomedicine, 10(3), 375–386. https://eprints.qut.edu.au/77824
- Tse, B., Jovanovic, L., Nelson, C., de Souza, P., Power, C. & Russell, P. (2014). From bench to bedside: Immunotherapy for prostate cancer. BioMed Research International, 2014, 1–11. https://eprints.qut.edu.au/77699
- Jacob, F., Anugraham, M., Pochechueva, T., Tse, B., Alam, S., Guertler, R., Bovin, N., Fedier, A., Hacker, N., Huflejt, M., Packer, N. & Heinzelmann-Schwarz, V. (2014). The glycosphingolipid P1 is an ovarian cancer-associated carbohydrate antigen involved in migration. British Journal of Cancer, 111(8), 1634–1645. https://eprints.qut.edu.au/77702
- Tse, B., Collins, A., Oehler, M., Zippelius, A. & Heinzelmann-Schwarz, V. (2014). Antibody-based immunotherapy for ovarian cancer: where are we at? Annals of Oncology, 25(2), 322–331. https://eprints.qut.edu.au/70630
- Russell, P., Tse, B. & Scott, K. (2012). Paradoxical roles of tumour necrosis factor-alpha in prostate cancer biology. Prostate Cancer, 2012, 1–8. https://eprints.qut.edu.au/55262
- Tse, B., Russell, P., Lochner, M., Forster, I. & Power, C. (2011). IL-18 inhibits growth of murine orthotopic prostate carcinomas via both adaptive and innate immune mechanisms. PLoS One, 6(9), 1–12. https://eprints.qut.edu.au/52296
QUT ePrints
For more publications by Brian, explore their research in QUT ePrints (our digital repository).